CONTENTS:
- Promoting reproducibility in addiction research [Editorial]. Munafo M.R., p. 1519-1520.
- Internet interventions for adult illicit substance users: a meta-analysis. Boumparis N., Karyotaki E., Schaub M.P., Cuijpers P., Riper H., p. 1521-1532.
- Commentary on Boumparis et al. (2017): It works, but only if they use it - addressing treatment adherence and attrition in internet interventions for illicit substance use. Stockings E.A., p. 1533-1534.
- Life-time risk of mortality due to different levels of alcohol consumption in seven European countries: implications for low-risk drinking guidelines. Shield K.D., Gmel G., Gmel G., Mäkelä P., Probst C., Room R., et al., p. 1535-1544.
- Commentary on Shield et al. (2017): The concept of 'acceptable risk' of premature mortality. Britton A., p. 1545-1546.
- Coping mediates the effects of cognitive-behavioral therapy for alcohol use disorder among out-patient clients in Project MATCH when dependence severity is high. Roos C.R., Maisto S.A., Witkiewitz K., p. 1547-1557.
- Hospitalizations, costs and outcomes associated with heroin and prescription opioid overdoses in the United States 2001-12. Hsu D.J., McCarthy E.P., Stevens J.P., Mukamal K.J., p. 1558-1564.
- Commentary on Hsu et al. (2017): A systems approach to improving health services for overdose in the hospital and across the continuum of care - an unmet need. Binswanger I.A., p. 1565-1566.
- Insular and cingulate attenuation during decision making is associated with future transition to stimulant use disorder. Stewart J.L., Butt M., May A.C., Tapert S.F., Paulus M.P., p. 1567-1577.
- Commentary on Stewart et al. (2017): Stimulants and marijuana - the potential value in studying substance co-use. Rabin R.A., Moeller S.J., p. 1578-1579.
- Risk to heroin users of polydrug use of pregabalin or gabapentin. Lyndon A., Audrey S., Wells C., Burnell E.S., Ingle S., Hill R., et al., p. 1580-1589.
- The economic burden of neonatal abstinence syndrome in the United States. Corr T.E., Hollenbeak C.S., p. 1590-1599.
- Associations between childhood maltreatment and non-medical use of prescription drugs among Chinese adolescents. Guo L., Xu Y., Deng J., Gao X., Huang G., Huang J., et al., p. 1600-1609.
- Effect of 0.5 mg versus 1 mg varenicline for smoking cessation: a randomized controlled trial. Fouz-Roson N., Montemayor-Rubio T., Almadana-Pacheco V., Montserrat-Garcia S., Gómez-Bastero A.P., Romero-Munoz C., et al., p. 1610-1619.
- Electronic cigarettes, quit attempts and smoking cessation: a 6-month follow-up. Pasquereau A., Guignard R., Andler R., Nguyen-Thanh V., p. 1620-1628.
- The role of novelty seeking as a predictor of substance use disorder outcomes in early adulthood. Foulds J.A., Boden J.M., Newton-Howes G.M., Mulder R.T., Horwood L.J., p. 1629-1637.
- Prescription contraception use and adherence by women with substance use disorders. Griffith G., Kumaraswami T., Chrysanthopoulou S.A., Mattocks K.M., Clark R.E., p. 1638-1646.
- Pharmacokinetics of concentrated naloxone nasal spray over first 30 minutes post-dosing: analysis of suitability for opioid overdose reversal. Mundin G., McDonald R., Smith K., Harris S., Strang J., p. 1647-1652.
- Cannabis, psychosis and schizophrenia: unravelling a complex interaction. Hamilton I., p. 1653-1657.
- Introduction of a new instrument to measure motivation for gaming: the electronic gaming motives questionnaire. Myrseth H., Notelaers G., Strand L.A., Borud E.K., Olsen O.K., p. 1658-1668.
- Significant reductions in alcohol use after hepatitis C treatment: results from the ANRS CO13-HEPAVIH cohort. Knight R., Roux P., Vilotitch A., Marcellin F., Rosenthal E., Esterle L., et al., p. 1669-1679.
- The narcotic clinic in New Orleans, 1919-21. Tallaksen A., p. 1680-1685.
- New psychoactive substances in Ireland following the criminal justice (psychoactive substances) act - why all the pessimism? Smyth B.P., p. 1686-1686.
- The contribution of unrecorded alcohol to health harm. Rehm J., Gmel G., Hasan O.S.M., Imtiaz S., Popova S., Probst C., et al., p. 1687-1688.
- Cannabis and psychotic experiences. Oh H., DeVylder J., p. 1688-1689.